Meyer Lab

What Meyer Lab does

Meyer Lab is a Paraguayan clinical laboratory network headquartered in Asunción, founded in 1992, operating seven service locations across the Greater Asunción metropolitan area with a 24/7 Casa Central. The company is the first molecular biology laboratory in Paraguay to achieve ISO 9001:2015 certification and also operates under ISO 15189. Its service menu spans two product lines: (1) routine clinical analysis covering hematology, endocrinology, chemistry, toxicology, microbiology, urinalysis, parasitology, and molecular biology; and (2) specialty genetic and molecular diagnostics including a 540-gene clinical exome panel, a 120-gene hereditary cancer suite, preconception carrier screening, multiplex PCR panels for HPV and genital ulcer pathogens, HLA-B27 detection, MLPA-based Duchenne-Becker testing, BCR-ABL1 p210 qRT-PCR quantification harmonized to International Scale, karyotyping, oligoclonal band detection, and autoimmune encephalitis antibody panels.

The underlying technology platform combines NGS, MLPA, real-time PCR, Sanger sequencing, and isoelectrofocusing/immunoblot with high levels of sample-processing automation. Genetic counseling is embedded across genetic test offerings. The PAC (Programa de Actualización Continua) functions as an educational platform for referring clinicians. Meyer Lab is a founding member of ALADIL (Latin American Diagnostics Laboratories association) since 2004 and maintains a referral alliance with Mayo Clinic Laboratories for specialized testing not available locally, alongside a strategic alliance with HÉRITAS Paraguay in precision medicine.

Revenue is generated through fee-for-service clinical testing for individual patients (B2C), pre-employment and periodic health examinations for corporate clients under Paraguayan labor regulations (B2B), home extraction services, and referral-network testing routed through partners such as NEO Diagnósticos. Pricing is not publicly disclosed and is quoted directly via phone, WhatsApp, or email. The company is privately held with 101-250 employees, no disclosed funding, and no public ownership or revenue data.

Name

Meyer Lab

Legal name

Meyer Lab

Website

https://meyerlab.com.py

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

101–250 employees

Short description

Meyer Lab is a Paraguayan clinical laboratory network operating seven locations in Greater Asunción, offering routine clinical analysis and specialty genetic/molecular diagnostics (NGS, MLPA, PCR) to individual patients, corporate clients, and physician referrals since 1992.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industries

Genetic & Prenatal Testing Laboratories (HLAFAMAH), Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics) (HLAAAMAJ)

Keywords

• Clinical laboratory services
• Molecular diagnostics
• Genetic testing
• Hereditary cancer panels
• Pathology services

Headquarters

HQ city

Asunción

HQ country

Paraguay

HQ region

Latin America

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Laboratory Testing Services: Core laboratory testing services including hematology, endocrinology, chemistry, toxicology, microbiology, urinalysis, parasitology and molecular biology. Services provided to individual patients, insured individuals, outpatients, and hospitalized patients at 7 locations across Paraguay.
2. Genetic and Molecular Testing: Specialized genetic testing including cancer hereditary panels, preconception carrier testing, neuromuscular disease testing, pharmacogenomics, and other NGS-based tests. Results delivered in 25-60 days depending on test complexity.
3. Corporate/Enterprise Health Services: Pre-employment and periodic health examinations for corporate employees as required by the Ministry of Labor, Employment and Social Security.
4. Home Extraction Services: At-home blood sample collection service for patient convenience.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

Meyer Lab operates a clinical laboratory network in Paraguay offering routine clinical analysis across Hematology, Endocrinology, Chemistry, Toxicology, Microbiology, Urinalysis, Parasitology and Molecular Biology, plus a specialized molecular diagnostics suite including NGS-based hereditary cancer panels, preconception carrier screening, conventional karyotyping, HPV genotyping, multiplex PCR panels, HLA-B27 PCR, BCR-ABL1 p210 quantification, MLPA, and Sanger sequencing. Services are delivered to individual patients across 7 physical locations with 24/7 service at Casa Central, supported by home sample collection, WhatsApp scheduling, and email-delivered results. The company also provides corporate pre-employment and periodic health examinations for businesses required to comply with Paraguay's Ministry of Labor regulations.

Product overview

Meyer Lab is a clinical laboratory network operating in Paraguay as the country's first ISO 9001:2015 certified molecular biology laboratory. The company offers a unified platform of clinical and specialized genetic diagnostic services, organized around two core product lines: (1) Análisis Clínicos (Clinical Analysis) — a broad menu spanning Hematology, Endocrinology, Chemistry, Toxicology, Microbiology, Urine, Parasitology, and Molecular Biology for general patients; and (2) Biología Molecular (Molecular Biology) — a specialized suite of genetic and genomic tests powered by NGS (next-generation sequencing), MLPA, real-time PCR, Sanger sequencing, and isoelectrofocusing/immunoblot techniques. Key molecular products include the Panel Exoma Clínico Dirigido (Análisis 540) for 540-gene targeted NGS panels, the multi-panel hereditary cancer testing (up to 120 genes, Análisis 58), preconception carrier screening panels (Análisis 649/650/652), conventional karyotyping (Análisis 5000/5001), HPV detection (Análisis 2100/2118), genital ulcer multiplex PCR (Análisis 2228), HLA-B27 PCR (Análisis 2192), BCR-ABL1 p210 qRT-PCR quantification, and autoimmune encephalitis/oligoclonal band panels. Services are supported by the Programa de Actualización Continua (PAC) educational platform and delivered through 7 locations in Asunción and surrounding areas with 24-hour service at Casa Central. Genetic counseling (pre- and post-test) is offered as an embedded service across all genetic testing offerings. The portfolio also includes routine pathology services (vaginitis cultures, STI panels) and company health screening services.

Differentiator

Problem solved

Functional benefit

Products and services

• Panel Exoma Clínico Dirigido (Análisis 540) Next-generation sequencing (NGS) panel analyzing 540 genes for directed clinical exome analysis, designed for patients based on clinical history and personal/family medical history. Covers panels for Marfan syndrome, Marfan-like syndromes, physiatry-related genetic diseases, and intermediate hereditary cancer panels including thyroid cancer and neurofibromatosis.
• Cáncer Hereditario (Hereditary Cancer) Panels Multi-panel hereditary cancer genetic testing analyzing up to 120 genes across pre-designed and custom panels covering breast/ovarian, colorectal, prostate, pancreatic, gastric, renal, thyroid, melanoma, Lynch syndrome, neurofibromatosis, and other syndromes. Includes pre- and post-test genetic counseling, with results delivered in 40 business days.
• Estudios Genéticos Preconcepcionales (Preconception Genetic Studies) Carrier screening panels for preconception genetic testing (Analysis 649 female FQ-FXS-AME; Analysis 650 female FQ-FXS-AME-DMD/B; Analysis 652 male FQ-AME). Screens for recessive genetic diseases including cystic fibrosis, Fragile X syndrome, spinal muscular atrophy, and Duchenne/Becker muscular dystrophy.
• Estudio de Cariotipo Convencional (Conventional Karyotype Study) Chromosomal analysis via G-banded karyotyping from peripheral blood lymphocyte metaphase cultures. Analysis 5000 covers 20-30 cells; Analysis 5001 covers 100 cells. Used for diagnosis of genetic syndromes (Down, Turner, Klinefelter), reproductive problems, and chromosomal abnormality detection, with results in 25 business days.
• HPV (Virus Papiloma Humano) Detección - Análisis 2100/2118 HPV detection by multiplex PCR for high and low oncogenic risk genotyping. Analysis 2100 detects 19 high-risk genotypes (16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 69, 73, 82) and 9 low-risk genotypes; Analysis 2118 covers 14 high-risk genotypes, with results in 4 days.
• Panel de Úlceras Genitales (Genital Ulcer Panel) - Análisis 2228 Multiplex PCR panel detecting up to 7 genital ulcer pathogens simultaneously: HSV-1, HSV-2, VZV, CMV, T. pallidum, H. ducreyi, and C. trachomatis L1-L3 from urine, genital swabs, cervical swabs, or oral/rectal lesions, with results in 24 hours.
• HLA-B27 Detección (PCR) - Análisis 2192 Real-time PCR detection of HLA-B27 alleles from genomic DNA in EDTA whole blood. Used as risk factor for spondyloarthropathies including ankylosing spondylitis, reactive arthritis, psoriatic arthritis, and enteropathic arthritis, with results in 5 days.
• Perfil de Anticuerpos para Miopatías Inflamatorias Myositis antibody profile panel evaluating 17 myositis-specific (MSA) and myositis-associated (MAA) antibodies. Used for diagnosis and characterization of dermatomyositis, polymyositis, antisynthetase syndrome, and necrotizing myopathy. Available through the Mayo Clinic Laboratories alliance.
• Evaluación de Encefalopatía Autoinmune/Paraneoplásica (Análisis 3019/3149) Autoimmune encephalitis panel evaluating 22 antibodies (anti-AMPA-R, anti-amphiphysin, anti-Glial nuclear Type 1, anti-Neuronal nuclear Types 1/2/3, anti-CASPR2, anti-CRMP-5, anti-DPPX, anti-GABA-B-R, anti-GAD65, anti-GFAP, IgLON5, anti-LGI1, anti-mGluR1, anti-Neurochondrin, anti-NIF, anti-NMDA-R, anti-Purkinje Cell Cytoplasmic Tr/Type 1/Type 2, anti-Septin 7). Tested in CSF (Analysis 3019) or serum (Analysis 3149).
• Bandas Oligoclonales, Suero + LCR (Análisis 3013) Oligoclonal band detection by isoelectrofocusing with immunoblot using paired CSF and serum samples. Used as a diagnostic tool for multiple sclerosis, detecting restricted intrathecal immunoglobulin G synthesis in over 90% of MS cases.
• Estudio Variante Familiar Conocida, Sanger (Análisis 620) Sanger sequencing for known familial mutation studies. Applied when a pathogenic mutation has been identified in an index case and testing other family members is needed; used for hereditary cancer and rare disease family variant studies, with approximately 80% cost reduction versus full panel testing and results in 60 business days.
• Cuantificación del Transcripto BCR-ABL1 p210 Quantitative real-time RT-PCR (qRT-PCR) for monitoring BCR-ABL1 p210 transcript levels (e13a2 and e14a2 variants) in chronic myeloid leukemia (CML) patients on tyrosine kinase inhibitor therapy. Results harmonized to the International Scale (IS) via validated conversion factor; ANM and CIO-FUCA certified since 2015; member of LABS. Also includes Analysis 2165 for BCR-ABL1 p210 detection.
• Distrofia Muscular Duchenne-Becker, Gen DMD, MLPA (Análisis 908) MLPA analysis of the DMD gene for detection of large deletions and/or duplications associated with Duchenne/Becker muscular dystrophy, detecting approximately 69% of cases. If inconclusive, full gene sequencing can follow, with results in 60 days.
• Diagnóstico de Vaginitis Vaginitis diagnostic services including differential diagnosis of vaginal discharge through smear and culture. Covers bacterial vaginosis (Gardnerella vaginalis), candidiasis (Candida spp.), trichomoniasis (Trichomonas vaginalis), Mycoplasma, Ureaplasma, Neisseria gonorrhoeae, and Streptococcus agalactiae.
• Panel de Neurofibromatosis y Afecciones Relacionadas NGS panel for diagnosis of neurofibromatosis type 1, type 2, and Legius syndrome. Covers genes NF1, NF2, SPRED1, LZTR1, SMARCB1, SMARCE1 with copy number variant (CNV) detection. Part of the Panel Cáncer Hereditario Intermedio offering.
• Análisis Clínicos (Clinical Analysis) Comprehensive clinical laboratory analysis menu spanning Hematology, Endocrinology, Chemistry, Toxicology, Microbiology, Urine, Parasitology, and Molecular Biology. Serves newborns, children, youth, adults, and elderly with personalized and warm care.
• Biología Molecular (Molecular Biology) Molecular biology laboratory services as Paraguay's first ISO 9001:2015 certified molecular biology lab. Employs next-generation technology including multiplex panels for simultaneous pathogen detection from single samples and high-degree automation in sample processing. Provides genetic counseling to physicians, patients, and fellow biochemists.

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature8 records

Partnerships

14 partnerships are on record, tiered core and minor.

• ALADIL (Asociación de Laboratorios de Diagnósticos de Latinoamérica)coreStrategic or Co-development Partner · 1 January 2004Founding member of ALADIL, representing Paraguay in this Latin American association of major diagnostic laboratories. The partnership provides access to global scientific and technological advances through semi-annual meetings held in different member countries. Meyer Lab hosted the meetings in 2012, 2017, and 2025.
• Mayo Clinic LaboratoriescoreStrategic or Co-development PartnerInternational reference laboratory partnership offering specialized testing not available locally. Mayo Clinic Laboratories is a world reference laboratory helping healthcare professionals advance patient care worldwide. Meyer Lab maintains an alliance to offer these specialized tests to Paraguayan patients.
• HÉRITAS ParaguaycoreStrategic or Co-development PartnerStrategic alliance for precision medicine services, providing genetic testing and medical genetics services in Paraguay.
• NEO DiagnósticoscoreStrategic or Co-development PartnerReferral network partner for specialized diagnostic testing services, with dedicated referral page on the NEO Diagnósticos website.
• LABS (Latin America BCR-ABL1 Standarization Study group)minorStrategic or Co-development PartnerMeyer Lab is a member of LABS study group for harmonization of BCR-ABL1 testing to International Scale standards.
• Cibic (Argentina)minorStrategic or Co-development PartnerALADIL member representing Argentina in the Latin American diagnostic laboratories network.
• Diagnósticos Do Brasil (Brazil)minorStrategic or Co-development PartnerALADIL member representing Brazil in the Latin American diagnostic laboratories network.
• Laboratorio Médico del Chopo (Mexico)minorStrategic or Co-development PartnerALADIL member representing Mexico in the Latin American diagnostic laboratories network.
• Asociación de Bioquímicos del Paraguay (ABP)minorOthersProfessional association membership supporting biochemistry professionals in Paraguay.
• Association for Diagnostics & Laboratory Medicine (ADLM)minorOthersInternational professional association membership for laboratory medicine.
• Cámara Paraguaya de Propietarios de Laboratorios de Análisis Clínicos (CAPROLAB)minorOthersNational chamber representing clinical analysis laboratory owners in Paraguay.
• Sociedad Científica del Paraguay (SCP)minorOthersScientific society membership supporting scientific research in Paraguay.
• Asociación Paraguaya para la Calidad (APC)minorOthersQuality association membership supporting quality standards in Paraguayan organizations.
• Asociación de Empresarios Cristianos (ADEC)minorOthersChristian business association membership.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Quest Diagnostics: U.S. clinical laboratory giant; comparable as a broad incumbent offering clinical and esoteric/molecular testing through reference-lab partnerships that compete with regional specialty labs like Meyer.
• SYNLAB: Europe-based global medical diagnostics services group operating across Latin America; a broad incumbent with overlapping clinical lab, genetic, and specialty testing capabilities across multiple countries.
• Dasa: Brazil's largest integrated diagnostics network; a broad incumbent across clinical analysis, molecular biology, and genomics with operating scale and brand advantage Meyer lacks as a single-country player.

Direct peers

• Diagnósticos do Brasil: Major Brazilian diagnostic laboratory and ALADIL member; comparable in scale and service mix (clinical + molecular biology) within the same regional Latin American diagnostics network.
• NEO Diagnósticos: Paraguayan diagnostic laboratory network and active referral partner of Meyer Lab; competes in the same Asunción market for clinical and molecular testing, with overlapping B2C and physician-referred patient flow.
• Laboratorio Médico del Chopo: Large Mexican clinical laboratory chain and ALADIL member; comparable in multi-branch DTC retail lab model with broad clinical analysis and molecular diagnostics offerings.
• Laboratorio Cibic: Argentina-based clinical and molecular diagnostics lab and ALADIL member; comparable regional peer with similar specialty testing breadth and physician-driven GTM in Latin America.
• HÉRITAS Paraguay: Paraguayan precision medicine and genetic testing provider allied with Meyer Lab; competes directly on hereditary panels, NGS testing, and genetic counseling for the same clinician and patient base.

Others

• Mayo Clinic Laboratories: U.S. reference laboratory allied with Meyer Lab; not a direct competitor in Paraguay but an enabling partner that provides esoteric testing access and could also serve as a competing reference destination for cross-border cases.

Emerging players

• Genetica (Genera): Latin American-focused genomic testing and precision medicine provider; comparable in NGS-based hereditary and preconception carrier panels, with overlapping target customer segments in the region.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/meyerlabpy
• YouTubeopen.spotify.com/show/4TXOOKBk1Z4WKRIIpe9twP
• Facebookfacebook.com/meyerlab.py
• LinkedInlinkedin.com/company/meyer-lab
• Instagraminstagram.com/meyerlab.py

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Meyer Lab